The Pharma Data

JUNE 26, 2021

Sanofi Aims for Carbon Neutrality Sanofi has committed to reduce its greenhouse gas emissions by 55% by 2030 in line with limiting global warming to 1.5°C C and is aiming for carbon neutrality by 2050. More on Sanofi’s environmental management and achievements: [link].

Packaging 52

Packaging Vaccine Production Science 52

The Pharma Data

APRIL 7, 2021

In this context, Sanofi, the only pharmaceutical company that keeps developing and supplying treatments for African trypanosomiasis or sleeping sickness, has committed itself alongside the WHO to eliminate this neglected tropical disease in humans by 2030. Zero plastic packaging for vaccines and ecodesign of products.

Vaccine 52

Vaccine Packaging Disease Treatment 52

Codon

MARCH 24, 2024

In the case of semaglutide, those cells are Saccharomyces cerevisiae— also known as Baker’s yeast — engineered to secrete a peptide precursor that is later purified, chemically modified, packaged into an injectable or tablet form, and then shipped around the world. Continuing this method may not scale.

Engineering 87

Engineering Vaccine Production RNA 87

The Pharma Data

JANUARY 9, 2021

• Anthrax Vaccines. Anthrax vaccine revenues are expected to be at a more normalized annual level and continue to primarily reflect procurement of AV7909 (Anthrax Vaccine Adsorbed, adjuvanted) under the Company’s existing contract with the Biomedical Advanced Research and Development Authority (BARDA).

Government 40

Government Vaccine Production Licensing 40

Codon

OCTOBER 27, 2024

The second part — focused on vaccines and medicines — will be published next Sunday, concluding Issue 04 of Asimov Press. Identifying the bacteria behind the pathogen would later set the stage for many upcoming diagnostics, treatments, and even a vaccine. But doctors explored numerous uninformed remedies in the interim.

Immune Response 94

Immune Response Doctors Disease Laboratories 94

Codon

FEBRUARY 23, 2025

Because of PEPFAR’s effectiveness, the United Nations (UN) set an ambitious goal in 2022 to end HIV transmission and eliminate AIDS-related deaths by 2030. A lifelong HIV vaccine would be ideal, but developing one has proved difficult. billion worth of doses — equivalent to 200,000 vaccines.

Clinical Trials 70

Clinical Trials Virus Vaccine DNA 70